Novocure Ltd
NVCR
NASDAQ·Healthcare·Medical - Devices·Mkt cap $2.1B
$17.64
▼ -1.07%
P/E
-13.57
Mkt Cap
$2.1B
52-Wk Range
$9.82–$21.45
52-Week Range
$9.82 - $21.45
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 47.6% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary Tumor Treating Fields technology with patent protection
- First-mover advantage in TTFields oncology applications
- Expanding clinical evidence across multiple solid tumor indications
- Global commercialization infrastructure and regulatory approvals
Bear Case
1 risk
- Average volatility.
Growth
Stable outlook
Expansion into new cancer indications through clinical trials
Value
Deep value opportunity - significant discount to Medical Devices peers
Momentum
Strong
+10.4% over 3m
Quality
Excellent
Solid business
Dividend
None
No dividend
Smart-money signal
Who's buying NVCR right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Oct 29, 2026
JUL 23, 2026
Reported EPS of -$0.13 vs -$0.33 consensus (+60.8% surprise). Revenue of $183.6M vs $172.4M expected (+6.5%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+60.8%
Revenue trend · last 8Q
—
+21%
+12%
+6%
+8%
+8%
+12%
+16%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$155.1M
$161.3M
$155.0M
$158.8M
$167.2M
$174.3M
$174.1M
$183.6M
Margins · last 8Q
Gross
77.6%
Operating
-5.8%
Profit
-8.5%
Wall Street consensus
4 analysts · 50% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
50%
Hold
50%
Sell
0%
Median Price Target
—
Latest: Wedbush · Jul 24, 2026
vs Industry
How NVCR stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related